title: Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient.
authors: M
authors: M
authors: Ostronoff
authors: F
authors: F
authors: Ostronoff
authors: R
authors: R
authors: Calixto
authors: R
authors: R
authors: Florêncio
authors: M
authors: M
authors: Florêncio
authors: M C
authors: MC
authors: Domingues
authors: A P
authors: AP
authors: Souto Maior
authors: A
authors: A
authors: Sucupira
authors: C
authors: C
authors: Tagliari
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D000069283:Rituximab; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab